Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity

被引:0
|
作者
D'Urzo, A. [1 ]
Singh, S. D. [2 ]
Kerwin, E. M. [3 ]
Lakkis, H. [4 ]
Chuecos, F. [5 ]
De Miquel, G. [5 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Manchester, Manchester, Lancs, England
[3] Clin Res Inst, Medford, MA USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] AstraZeneca Plc, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5783
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By Inhaled Corticosteroid Use
    Bateman, E. D.
    Chapman, K. R.
    Rennard, S. I.
    Lakkis, H.
    Moya, M.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] The AUGMENT COPD Trial: Efficacy and Safety of a Fixed-Dose Combination of Aclidinium Bromide and Formoterol Fumarate in COPD Patients
    D'Urzo, Anthony
    Rennard, Stephen
    Mergel, Victor
    Gil, Esther Garcia
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2014, 145 (03)
  • [3] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In A Pooled Population Of Patients With COPD, Stratified By Age
    Mroz, R. M.
    Scanlon, P.
    Donohue, J. F.
    Molins, E.
    Lakkis, H.
    De Miquel, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [4] Long-term Safety of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate in Patients With Stable Moderate to Severe COPD
    Make, Barry
    Donohue, James
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2014, 145 (03)
  • [5] Efficacy and safety of fixed-dose combination aclidinium bromide/formoterol fumarate in patients with COPD: Results from the AUGMENT COPD trial
    D'Urzo, Anthony
    Mergel, Victor
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [6] Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial
    Rennard, S. I.
    D'Urzo, A. D.
    Donohue, J. F.
    He, T.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] EFFICACY AND SAFETY OF ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION IN PATIENTS WITH COPD, STRATIFIED BY ICS USE
    Singh, D.
    D'Urzo, A.
    Garcia Gil, E.
    THORAX, 2015, 70 : A36 - A37
  • [8] Efficacy Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate On Bronchodilation Over 1 Year: Augment COPD Extension Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    He, T.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [9] Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity ;
    D'Urzo, Anthony D.
    Singh, Dave
    Kerwin, Edward
    Lakkis, Hassan
    Chuecos, Ferran
    De Miguel, Gonzalo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Safety And Tolerability Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Make, B. J.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189